Trial Outcomes & Findings for Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence (NCT NCT00300235)

NCT ID: NCT00300235

Last Updated: 2019-02-01

Results Overview

Subject responded YES to survey Question "Have you ever had priapism?". By diagnosis and age group. Enumeration of the prevalence of priapism in males with sickle cell anemia and sickle beta zero thalassemia.

Recruitment status

COMPLETED

Target enrollment

1464 participants

Primary outcome timeframe

At time of interview

Results posted on

2019-02-01

Participant Flow

Participant milestones

Participant milestones
Measure
Age 5-9.9 HbSS/HbSβ0
Subjects 5 to 9.9 yrs w/SCD diagnosis HbSS/HbSβ0
Age 10-14.9 HbSS/HbSβ0
Subjects 10 to 14.9 ys w/SCD diagnosis HbSS/HbSβ0
Age 15-24.9 HbSS/HbSβ0
Subjects 15 to 24.9 yrs w/SCD diagnosis HbSS/HbSβ0
Age >25 HbSS/HbSβ0
Subjects \> 25 yrs w/SCD diagnosis HbSS/HbSβ0
Age >15 HbSC/HbSβ+
Subjects \> 15 yrs w/SCD diagnosis HbSC/HbSβ+
Overall Study
STARTED
208
240
398
362
251
Overall Study
COMPLETED
208
240
398
362
251
Overall Study
NOT COMPLETED
0
0
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Age 5-9.9 HbSS/HbSβ0
n=208 Participants
Subjects 5 to 9.9 yrs w/SCD diagnosis HbSS/HbSβ0
Age 10-14.9 HbSS/HbSβ0
n=240 Participants
Subjects 10 to 14.9 ys w/SCD diagnosis HbSS/HbSβ0
Age 15-24.9 HbSS/HbSβ0
n=398 Participants
Subjects 15 to 24.9 yrs w/SCD diagnosis HbSS/HbSβ0
Age >25 HbSS/HbSβ0
n=362 Participants
Subjects \> 25 yrs w/SCD diagnosis HbSS/HbSβ0
Age >15 HbSC/HbSβ+
n=251 Participants
Subjects \> 15 yrs w/SCD diagnosis HbSC/HbSβ+
Total
n=1459 Participants
Total of all reporting groups
Age, Categorical
<=18 years
208 Participants
n=5 Participants
240 Participants
n=7 Participants
203 Participants
n=5 Participants
0 Participants
n=4 Participants
84 Participants
n=21 Participants
735 Participants
n=10 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
195 Participants
n=5 Participants
361 Participants
n=4 Participants
165 Participants
n=21 Participants
721 Participants
n=10 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
2 Participants
n=21 Participants
3 Participants
n=10 Participants
Age, Continuous
7.4 years
STANDARD_DEVIATION 1.44 • n=5 Participants
12.6 years
STANDARD_DEVIATION 1.46 • n=7 Participants
19.3 years
STANDARD_DEVIATION 2.72 • n=5 Participants
36.0 years
STANDARD_DEVIATION 8.93 • n=4 Participants
29.8 years
STANDARD_DEVIATION 13.69 • n=21 Participants
22.5 years
STANDARD_DEVIATION 12.65 • n=10 Participants
Sex: Female, Male
Female
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
0 Participants
n=10 Participants
Sex: Female, Male
Male
208 Participants
n=5 Participants
240 Participants
n=7 Participants
398 Participants
n=5 Participants
362 Participants
n=4 Participants
251 Participants
n=21 Participants
1459 Participants
n=10 Participants
Region of Enrollment
United States
208 participants
n=5 Participants
240 participants
n=7 Participants
398 participants
n=5 Participants
362 participants
n=4 Participants
251 participants
n=21 Participants
1459.0 participants
n=10 Participants

PRIMARY outcome

Timeframe: At time of interview

Population: All particpants who completed survey were analyzed.

Subject responded YES to survey Question "Have you ever had priapism?". By diagnosis and age group. Enumeration of the prevalence of priapism in males with sickle cell anemia and sickle beta zero thalassemia.

Outcome measures

Outcome measures
Measure
Age 5-9.9 HbSS/HbSβ0
n=208 Participants
Subjects 5 to 9.9 yrs w/SCD diagnosis HbSS/HbSβ0
Age 10-14.9 HbSS/HbSβ0
n=240 Participants
Subjects 10 to 14.9 ys w/SCD diagnosis HbSS/HbSβ0
Age 15-24.9 HbSS/HbSβ0
n=398 Participants
Subjects 15 to 24.9 yrs w/SCD diagnosis HbSS/HbSβ0
Age >25 HbSS/HbSβ0
n=362 Participants
Subjects \> 25 yrs w/SCD diagnosis HbSS/HbSβ0
Age >15 HbSC/HbSβ+
n=251 Participants
Subjects \> 15 yrs w/SCD diagnosis HbSC/HbSβ+
Enumeration of the Prevalence of Priapism in Males With Sickle Cell Anemia and Sickle Beta Zero Thalassemia.
18 participants
58 participants
160 participants
189 participants
60 participants

SECONDARY outcome

Timeframe: Cross-sectional single survey visit

Characterization of priapism in males with sickle cell anemia with reference to time of onset, duration of events, frequency of episodes, precipitating or associated activities, treatment modalities used, and outcome of treatments.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Cross-sectional single survey visit

Descriptive comparison of the prevalence of priapism in males with sickle cell anemia to that described in older patients with other sickle hemoglobinopathies.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Cross-sectional single survey visit

Assessment of general patient and parent understanding of priapism as a complication of sickle cell disease gained from completion of protocol.

Outcome measures

Outcome data not reported

Adverse Events

Age 5-9.9 HbSS/HbSβ0

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Age 10-14.9 HbSS/HbSβ0

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Age 15-24.9 HbSS/HbSβ0

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Age >25 HbSS/HbSβ0

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Age >15 HbSC/HbSβ+

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Karen Kesler, PhD

Rho Federal Systems Division

Phone: 919-408-8000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place